REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genomtec S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Rental and Leasing Services | Specialized Design Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Genomtec S.A. Profile Updated: February 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Genomtec is a technology company specializing in clinical diagnostics. The company focuses on developing innovative products for genetic analysis, with a main product called Genomtec ID, a small analyzer for fast and accurate genetic analysis. They also offer the Genomtec SARS-CoV-2 EvaGreen Direct product line for detecting variants of coronavirus. Genomtec utilizes optical systems and the isothermal method of multiplication of nucleic acids in their operations.

Headquarters
ul. Bierutowska 57-59
Wroclaw; Dolnoslaskie; Postal Code: 51-317

Contact Details: Purchase the Genomtec S.A. report to view the information.

Website: http://www.genomtec.com

Basic Information
Total Employees:
Purchase the Genomtec S.A. report to view the information.
Outstanding Shares:
Purchase the Genomtec S.A. report to view the information.
Registered Capital:
Purchase the Genomtec S.A. report to view the information.
Financial Auditors:
Purchase the Genomtec S.A. report to view the information.
Incorporation Date:
February 10, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
10%
Purchase this report to view the information.
8.01%
Subsidiaries
Gmt Genomics S.A.
100%
Gmt Id S.A.
100%
Company Performance
Financial values in the chart are available after Genomtec S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
53.02%▲
Total operating revenue
37.75%▲
Operating Profit/Loss (EBIT)
2.89%▲
EBITDA
2.89%▲
Net Profit/Loss for the Period
2.13%▲
Total Assets
-5.03%▼
Total Equity
36.16%▲
Operating Profit Margin (ROS)
298.01%▲
Net Profit Margin
299.08%▲
Return on Equity (ROE)
34.51%▲
Debt/Equity
-15.42%▼
Quick Ratio
1.27%▲
Cash Ratio
1.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo